Evidence map›Paper›PMID 37966229›Full record

ArticleAntimicrobial agents and chemotherapy2023

Epidemiology and impact of methicillin-sensitive

J Svishchuk, K Ebbert, B Waddell, C Izydorczyk, N Acosta, R Somayaji, H R Rabin, C L Bjornson, L Lisboa, D B Gregson and 3 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Microbial and host innate immune factors affecting the persistence ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

J SvishchukDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
K EbbertDepartment of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
B WaddellDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
C IzydorczykDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
N AcostaDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
R SomayajiDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
H R RabinDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
C L BjornsonDepartment of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
L LisboaDepartment of Pathology and Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada.
D B GregsonDepartment of Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada.
J M ConlyDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
M G SuretteDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0003-0086-4995
M D ParkinsDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-3749-7930
University of Calgary · CAAlberta Health Services · CAMcMaster University · CA

Funding

Alberta Precision Laboratories (APL)Cystic Fibrosis Foundation (CFF)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisStaphylococcal InfectionsAdolescentAdultAnti-Bacterial Agentsbeta Lactam AntibioticsCefazolinCeftazidimeHumansMethicillinMicrobial Sensitivity TestsMonobactamsPiperacillin, Tazobactam Drug CombinationProspective StudiesStaphylococcus aureusAnti-Bacterial Agentsbeta Lactam AntibioticsCefazolinCeftazidimeMethicillinMonobactamsPiperacillin, Tazobactam Drug Combinationantimicrobial resistancebacteremiablaZbronchiectasiscefazolinexacerbationMSSApiperacillin-tazobactam

Identifiers

PMID37966229
PMCPMC10720481
OpenAlexW4388698171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.